4//SEC Filing
Arix Bioscience Holdings Ltd 4
Accession 0000899243-20-008474
CIK 0001672619other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:04 PM ET
Size
11.3 KB
Accession
0000899243-20-008474
Insider Transaction Report
Form 4
IMARA Inc.IMRA
Arix Bioscience Holdings Ltd
10% Owner
Transactions
- Purchase
Common Stock
2020-03-16$16.00/sh+187,500$3,000,000→ 1,554,558 total(indirect: By entities affiliated with Arix Bioscience plc) - Conversion
Common Stock
2020-03-16+1,367,058→ 1,367,058 total(indirect: By entities affiliated with Arix Bioscience plc) - Conversion
Series B Preferred Stock
2020-03-16−8,611,110→ 0 total(indirect: By entities affiliated with Arix Bioscience plc)→ Common Stock (1,367,058 underlying)
Arix Bioscience plc
10% Owner
Transactions
- Purchase
Common Stock
2020-03-16$16.00/sh+187,500$3,000,000→ 1,554,558 total(indirect: By entities affiliated with Arix Bioscience plc) - Conversion
Common Stock
2020-03-16+1,367,058→ 1,367,058 total(indirect: By entities affiliated with Arix Bioscience plc) - Conversion
Series B Preferred Stock
2020-03-16−8,611,110→ 0 total(indirect: By entities affiliated with Arix Bioscience plc)→ Common Stock (1,367,058 underlying)
Footnotes (2)
- [F1]On March 16, 2020, the Issuer's Series B Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]These shares are owned directly by Arix Bioscience Holdings Limited, which is a wholly owned subsidiary of Arix Bioscience Plc. Arix Bioscience Plc is an indirect beneficial owner of the reported securities and disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
Documents
Issuer
IMARA Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001756884
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 5:04 PM ET
- Size
- 11.3 KB